| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ars Pharmaceuticals, Inc. (SPRY) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 31 sells. SPRY is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 4.89M | $47.16M | - | |
| Dir | 4.47M | $43.18M | - | |
| Other | 240.0K | $2.32M | - | |
| Other | 240.0K | $2.32M | - | |
| CEO | 240.0K | $2.32M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 19, 2024 | Tanimoto Sarina54 | Chief Medical Officer | Sell | 100,000 | $13.95 | $1,394,960.00 | -3.8% | -14.6% | -48.6% | |
| Nov 19, 2024 | Lowenthal Richard E54 | President And CEO | Sell | 100,000 | $13.95 | $1,394,960.00 | -3.8% | -14.6% | -48.6% | |
| Nov 12, 2024 | Lowenthal Richard E54 | President And CEO | Sell | 100,000 | $16.85 | $1,684,642.45 | -1.9% | -29.3% | -46.1% | |
| Nov 12, 2024 | Tanimoto Sarina54 | Chief Medical Officer | Sell | 100,000 | $16.85 | $1,684,642.45 | -1.9% | -29.3% | -46.1% | |
| Nov 12, 2024 | Flynn James E62 | 10% Owner | Sell | 563,270 | $18.01 | $10,143,705.51 | -1.3% | -29.3% | -46.1% | |
| Oct 16, 2024 | Scott Kathleen D.64 | Chief Financial Officer | Sale+OE | 12,500 | $16.00 | $200,000.00 | -71.6% | -31.2% | -38.8% | |
| Oct 15, 2024 | Tanimoto Sarina54 | Chief Medical Officer | Sell | 100,000 | $14.88 | $1,487,595.07 | -2.4% | -26.1% | -28.0% | |
| Oct 15, 2024 | Lowenthal Richard E54 | President And CEO | Sell | 100,000 | $14.88 | $1,487,595.07 | -2.4% | -26.1% | -28.0% | |
| Oct 8, 2024 | Tanimoto Sarina54 | Chief Medical Officer | Sell | 100,000 | $13.83 | $1,382,775.00 | -3.6% | -20.2% | -20.0% | |
| Oct 8, 2024 | Lowenthal Richard E54 | President And CEO | Sell | 100,000 | $13.83 | $1,382,775.00 | -3.6% | -20.2% | -20.0% |